1. Home
  2. FRT vs PCVX Comparison

FRT vs PCVX Comparison

Compare FRT & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Federal Realty Investment Trust

FRT

Federal Realty Investment Trust

N/A

Current Price

$112.30

Market Cap

10.1B

Sector

Real Estate

ML Signal

N/A

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

N/A

Current Price

$60.61

Market Cap

7.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FRT
PCVX
Founded
1962
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1B
7.0B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
FRT
PCVX
Price
$112.30
$60.61
Analyst Decision
Buy
Strong Buy
Analyst Count
13
4
Target Price
$112.08
$88.25
AVG Volume (30 Days)
564.4K
1.0M
Earning Date
05-01-2026
05-07-2026
Dividend Yield
4.09%
N/A
EPS Growth
36.84
N/A
EPS
1.81
N/A
Revenue
$1,278,975,000.00
N/A
Revenue This Year
$6.10
N/A
Revenue Next Year
$4.64
N/A
P/E Ratio
$62.88
N/A
Revenue Growth
6.36
N/A
52 Week Low
$90.03
$30.81
52 Week High
$128.21
$65.00

Technical Indicators

Market Signals
Indicator
FRT
PCVX
Relative Strength Index (RSI) 30.16 55.15
Support Level $112.67 $58.51
Resistance Level $119.41 $63.39
Average True Range (ATR) 1.50 1.98
MACD -0.15 -0.28
Stochastic Oscillator 7.01 54.29

Price Performance

Historical Comparison
FRT
PCVX

About FRT Federal Realty Investment Trust

Federal Realty Investment Trust is a shopping center-focused retail real estate investment trust that owns high-quality properties in eight of the largest metropolitan markets. Its portfolio includes an interest in 103 properties, which includes 28.8 million square feet of retail space and 2,500 multifamily units. Federal's retail portfolio includes grocery-anchored centers, superregional centers, power centers, and mixed-use urban centers. Federal Realty has focused on owning assets in highly desirable areas with significant growth, and as a result, the average population density and average median household income are higher for its portfolio than for any other retail REIT.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: